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Correlation between Serum Ferritin, Serum Cystatin C, and Renal Function 
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AbstractRenal dysfunction caused by iron overload is characterized by an increase in ferritin and  cystatin C levels. The objective of  this study was to determine the correlation between ferritin, cystatin C, and renal function in children 
with β thalassemia major. A cross-sectional observational analytic study was conducted in September 2018 on 34 
children with β thalassemia major in Dr. Hasan Sadikin General Hospital Bandung. Ferritin and cystatin C levels 
were documented and the estimated glomerular filtration rate (eGFR) was calculated using the Schwartz formula. Statistical tests were performed using Rank Spearman and Point Biserial with p value of <0.05 considered 
significant. the median ferritin level, cystatin C level, and eGFR of the subjects were 2,818 ng/mL (95% CI: 2,505–
3,977), 209.9±121.5 (95% CI: 167.5–252.3), and 185.5 mL/min /1.73 m2 (95% CI: 173.6–208.2), respectively. 
Correlations were sought between serum ferritin  and eGFR (r=0.132, p=0.229), between cystatin C and eGFR: 
r=0.3012, p=0.041, and between ferritin and cystatin C: r=0.433, p=0.011. No correlation was found between 
ferritin and renal function whereas serum cystatin C presented a positive correlation with renal function. A strong correlation was found between ferritin and cystatin C. Serum ferritin and cystatin C are promising biomarkers to 
assist in monitoring renal function in children with β thalasemia major.
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Hubungan Feritin dan Cystatin C Serum dengan Fungsi Ginjal 
pada Anak Talasemia β Mayor
Abstrak
Kelebihan besi pada anak talasemia β mayor mengganggu organ vital di antaranya ginjal. Gangguan fungsi ginjal karena kelebihan besi dapat ditandai dengan peningkatan kadar ferritin  dan cystatin C. Penelitian ini bertujuan mengetahui hubungan kadar feritin dan cystatin C dengan fungsi ginjal pada anak talasemia β mayor. Penelitian observasional analitik dengan rancangan potong lintang, dilaksanakan bulan September 2018. Subjek penelitian 
adalah anak penderita talasemia β mayor di Rumah Sakit Dr. Hasan Sadikin Bandung. Dilakukan pemeriksaaan kadar feritin dan cystatin C. Penilaian fungsi ginjal menggunakan estimated glomerular filtration rate (eGFR) dengan formula Schwartz. Uji statistik menggunakan uji Rank Spearman dan Point Biserial dengan kemaknaan 
berdasar nilai p<0,05. Didapatkan jumlah sampel sebanyak 34 anak, dengan kadar feritin median 2818 ng/
mL (IK95%:2505–3977), cystatin C 209,9±121,5 (IK95%:167,5–252,3) dan eGFR median 185,5 mL/menit per 1,73 m2(IK95%:173,6–208,2). Korelasi antara kadarferritin dengan eGFR (r=0,132; p=0,229), korelasi cystatin 
C dengan eGFR (r=0,3012; p=0,041) dan korelasi kadar feritin dengan cystatin C (r=0,433; p=0,011). Hasil penelitian ini tidak didapatkan korelasi antara feritin dan fungsi ginjal, sedangkan cystatin C memiliki korelasi positif dengan fungsi ginjal. Didapatkan  korelasi kuat antara kadar feritin dan cystatin C serum. Pemeriksan kadar feritin dan cystatin C dapat membantu  pemantauan fungsi ginjal pada anak talasemia β mayor.
Kata kunci: Anak talasemia β mayor, cystatin c, ferritin, fungsi ginjal
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IntroductionThalassemia is the most common inherited hemoglobinopathies in the world.1 World 
Health Organization (WHO) stated that this hemoglobin abnormality causes a serious health problem in 229 countries and Indonesia is one of the countries with the highest number of thalassemia patients. Inadequate attention has been paid to renal dysfunction in children with 
β thalassemia since previous studies mostly only focused on adult patients when  subclinical renal dysfunction is more common and could start earlier in thalassemia patients. Because red blood cell transfusion is the main treatment for thalassemia, iron excess may happen due to iron accumulation from repetitive blood transfusion, hemolysis, and body’s compensation in the form of accelerated iron absorption caused by ineffective erythropoiesis. Ferritin serum testing nowadays are widely performed as an easy and trusted method to check iron concentration in the body.2–5
Iron excess in β thalassemia major is believed lead to various organ systems disruptions, such as dysruptions in the heart, lungs, liver, endocrine glands, and, also, kidneys. Renal dysfunction can  also be caused by previous anemia history, chronic hypoxia, or as the complication of iron chelation therapy. Poor chelation is an important risk factor for early renal affection.6,7 Renal 
dysfunction inβ thalassemia major can be found in glomerulus or tubules and the parameter used to determine renal function is the glomerular 
filtration rate (GFR). The increasing level of ferritin serum will lead to GFR decline since iron excess damage renal’s glomerulus and tubules.3 
Endogen filtration marker test, such as serum creatinine and cystatin C, can be used in daily clinical practice since it is considered more convenient than the inulin test. Cystatin C level is closer to the GFR than the creatinine level.6–9This study was performed to determine the correlation between serum ferritin, serum 
cystatin C, and renal function in children with β thalassemia major.
Methods
This was a cross-sectional analytical observational 
study on β thalassemia major children, selected w consecutively. The sample size was determined using the sample size formula for correlation 
coefficient and a minimum of 34 subjects were required based on the formula. The exclusion 
criteria was β thalassemia major children with 
systemic dysfunction/s (heart failure, liver 
failure, or diabetes mellitus) and who had been proven to experience renal dysfunction, both clinically and based on laboratory results. This study was performed in pediatric thalassemia outpatient ward in Dr. Hasan Sadikin General Hospital Bandung, Indonesia during the month 
of September 2018 after obtaining the approval 
from the hospital’s  Ethical Committee through the issuance of the ethical clearance number 
LB.04.01/A05/EC/244/VIII/2018. The parents of subject study had consented to their child’s participation  in the study, which was proven by 
signing the informed consent form. Anamnesis and physical examination were performed on the subjects to eliminate systemic abnormalities and anthropometric examination using WHO 
Growth Chart Standards (WCGS) curve was 
done and 5 mL blood sample was drawn  from the peripheral venous. The blood samples were sent to the Pathological Clinic laboratory of the hospital to determine the ferritin serum level 
using Centaur XPT (Siemens). The determination of cystatin C serum level was performed using the 
human cystatin C immunosorbent assay (ELISA) kit added with hemoglobin level measurement using Sysmex complete blood count analyzer and creatinine serum measurement using Jaffe 
method (Siemens, 2016-12 version, USA).The GFR assessment was performed using 
estimated Glomerular Filtration Rate (eGFR) 
followed with the use of Schwartz formula– eGFR 
for children (1.73 m2/mL/minute)= body height 
(cm) x constant number/serum creatinine 
(mg/dL), with the constant number of 0.44 for children <2 years old and 0.55 for children >2 years old. Patients were said to suffer from 
renal dysfunction if the GFR value was <90 mL/minute/1.73 m2. A persistent reduction in the 
GFR of <60 mL/minute/1.73 m2 was defined as chronic kidney disease. The interpretation of GFR estimates depend on the clinical context. Patients with  renal damage markers, such as proteinuria or abnormalities on imaging studies or presence of diseases on kidney biopsy, were considered to suffer from renal dysfunction  even 
if the GFR estimates were 60 mL/minute/1.73 m2or greater.10Data obtained were then recorded in SPSS® software for windows in version 25. Independent variable in this study was serum ferritin and cystatin levels while the dependent variable was the GFR. The correlation was analyzed using Rank Spearman Correlation for numerical data if data was not normally distributed and  Point 
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Table Subject Characteristics
Variable
Normal 
value
n (%)
n=34
Mean ± SD
Or
Median (IQR)
CI 95%
Age (years)GenderMaleFemale
Body weight (kg)
Body height (cm)Nutritional statusGoodMalnourished
Hemoglobin (g/dL)
Creatinine (mg/dL)
Ferritin (ng/mL)
Cystatin C (ng/mL)
eGFR(mL/minutes/1,73 m2)
–
–
–
11.5–14.5
0.03–0.88
10–300
580–1380<90
22 (64.7)
12 (35.3)
2 (5.9)
32 (94.1)
6.9±1.3
9±4
21.2±7.2
115.4±18.5
6.5–7.4
0.36±0.09
2818 (2662)
209.9±121.5
185.5 (50.3)
7–10
18.7–23.7
108.9–121.9
20.9–26.7
0.33–0.39
2502–3977
167.5–252.3
173.6–208.2
Note: SD=standard deviation, IQR=inter quartile range, CI=confidence interval
Figure 1 Scatterplot Fort Ferritin against Cystatin C
Biserial Correlation was used to determine the correlation between categorical and numerical data. Correlation strength value was determined 
as 0.000–0.1999 (very weak), 0.200–0.399 
(weak), 0.400–0.599 (moderate), 0.600–0.799 
(strong), 0.800–1.000 (very strong). The p value 
for significance was <0.05.
Results The characteristics data of the subjects in this study study include data on age, gender, 
nutritional status, hemoglobin level, creatinine, ferritin, cystatin C, and eGFR as listed in Table.The correlation between serum ferritin and 
cystatin C was also analyzed and a significant 
correlation was identified (r=0.433, p=0.011), meaning that the higher the serum ferritin level is, the higher serum cystatin C level.
Discussion
Quality of life improvement in β thalassemia 
major children creates a long-term iron excess 
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effect in vital organs such as liver, pancreas, heart, and kidneys. Renal dysfunction could be asymptomatic long before severe manifestations appear. Renal dysfunction is mostly multifactorial, possibly caused by previous anemia history, chronic hypoxia, iron excess, and iron chelation therapy.11This study found no correlation between serum ferritin level and GFR. High serum ferritin 
levels can reflect the condition of excess iron in the body, which is one of the causes of impaired renal function in patients with thalassemia 
β major.3,5 The median serum ferritin level in 
this study was 2,818 ng/dL, which was higher than the normal value. One study stated that the average serum ferritin value is different in each country.5 A study in Egypt regarding the examination of cystatin C as an early biomarker 
of renal abnormalities in adult patients with β thalassemia major has found an increase in serum ferritin level accompanied by a decrease in GFR.1 
Another study in Canada on renal dysfunction in thalassemia sufferers found no correlation between serum ferritin level and impaired renal function.12 The lack of correlation between ferritin and GFR could be caused by a relatively increased GFR in the present study, caused by the overestimated GFR value due to malnourishment 
in 32 subjects (94.1%). Low creatinine level was 
observed in this study (0.36±0.09 mg/dL) that 
may relate to the malnourished condition. Low creatinine level is triggered by low muscle mass and low creatinine production in malnourished children and this may lead to overestimated GFR value which cannot corrected with lower body height in malnourished children. Since malnourished children tend to have lower creatinine level, Schwartz formula should not be used for malnourished children.13Cystatin C serum analysis showed a positive 
correlation with GFR. A previous study in Egypt regarding the examination of cystatin C as an early biomarker of renal abnormalities in adult 
patients with β thalassemia major obtained a negative correlation between serum cystatin C and GFR.1 Examination of cystatin C was said to be more sensitive in assessing renal abnormalities compared to serum creatinine, because serum cystatin C can detect a small decrease in GFR.9,10 In this study, serum cystatin C level was normal and the GFR value relatively increased in all 
subjects. This is similar to the finding in a study in Iran on renal function in various types of thalassemia patients and a study in Canada about renal dysfunction in thalassemia patients.12,14 This condition occurs because of glomerular 
hyperfiltration that is caused by anemia that a decrease in systemic resistance of blood vessels occurs, causing hyperdynamic circulation that 
will increase blood flow to the kidneys, resulting in an increase in GFR.15–17 The study concluded that  renal function disorders do not occurred in all subjects but the GFR will decrease with age, especially in patients who do not routinely receive transfusions. In the long term, chronic hypoxia can cause a progressive decrease in GFR, due to apoptosis and tubular interstitial damage, until glomerular sclerosis and renal 
fibrosis occur. Studies  in Italy on the long-term 
follow-up of renal function in βthalassemia major patients stated that a progressive decline 
will occur at the age of 20–30 years.4,18,19 This situation is aggravated by the excess iron which causes damages to glomerular cells and tubules. These damaged cells then  secrete cytokines and growth factors that can alsotrigger glomerular and tubular sclerosis.17
A significant correlation between serum ferritin level and serum cystatin C levels was found in this study with the higher the serum ferritin level is, the higher the serum cystatin C level. This increased serum ferritin that is accompanied by an increase in serum cystatin C 
is similar to the finding in Egypt  that suggested cystatin C as a good marker to help monitor renal dysfunction from small changes in GFR with 
higher sensitivity and specificity than creatinine. In their conclusion, they mentioned that renal 
dysfunction in β thalassemia major is not rare complication that  markers such as cystatin C are useful for early detection of small changes in GFR.1,6,20There are limitations in our study due to 
its design as a cross-sectional study that it is 
not possible to follow the β thalassemia major patients over time. In conclusion, a strong correlation between serum ferritin level and serum cystatin C level is observed. Serum ferritin and cystatin C are promising biomarkers to assist in monitoring 
renal function in children with β thalasemia major.
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